Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes

First-generation HCV protease inhibitors represent a milestone in antiviral therapy for chronic hepatitis C infection (CHC), but substantially increased rates of viral clearance are offset by increased rates of infection and infection-associated deaths, especially of patients with advanced liver dis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Spindelboeck, Walter, Horvath, Angela, Tawdrous, Monika, Schmerböck, Bianca, Zettel, Gabriele, Posch, Andreas, Streit, Andrea, Jurse, Petra, Lemesch, Sandra, Horn, Martin, Wuensch, Gerit, Stiegler, Philipp, Stauber, Rudolf E., Leber, Bettina, Stadlbauer, Vanessa
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777445/
https://ncbi.nlm.nih.gov/pubmed/26938078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0150299
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items